3P Biopharmaceuticals appoints Kenneth McMahon as Head of Quality Control

Kenneth McMahon has a PhD in molecular microbiology and a solid experience of over 10 years in both Quality Assurance (QA) and Quality Control (QC) departments.

Noáin, Spain, September 12, 2022] 3P Biopharmaceuticals (3P), a leading organization specializing in the development of cGMP processes and manufacturing of biological products (CDMO) appoints a new member as head of quality control.

Kenneth McMahon has a PhD in molecular microbiology and a solid experience of over 10 years in both Quality Assurance (QA) and Quality Control (QC) departments. He joined 3P with the objective of controlling and ensuring the correct quality of the manufactured products as well as compliance with the approved safety criteria.
He began his professional career in quality control at Genzyme (now Sanofi). In 2015 he joined the quality department at Bristol Myers Squibbs and since then he has continued to develop his knowledge and skills in the field of pharmaceutical quality.
After that, he worked for 4 years in positions of responsibility within the Quality Assurance and Quality Control departments at Samsung Biologics.
His professional career has been developed in GMP environments, and he is an expert in the design, development, and implementation of pharmaceutical quality systems, as well as in the management and quality control of pharmaceutical products.

“Joining a company like 3P is a fantastic opportunity to further develop my career and to be able to move back to Europe. I look forward to contributing successfully to their quality strategy”. Kenneth said on his arrival at the Noáin-based company.
Dámaso Molero, CEO of 3P Biopharmaceuticals said: “As an international company, we are excited to welcome Kenneth to our team. His extensive experience in senior quality positions will undoubtedly help us to strengthen the area to continue providing a high level of service”.

Therefore, with this new addition to the quality department, 3P continues its growth plan and consolidates its competitive position as one of the leading CDMOs in Europe.

About 3P Biopharmaceuticals
3P Biopharmaceuticals is a market-leading CDMO (Contract Development and Manufacturing Organization) specializing in process development and GMP (Good Manufacturing Practice) manufacturing of biologics and cell therapy products. 3P offers solutions for all stages related to new drug and biosimilar development and manufacturing including cell line and process development, analytical methods development, pre-clinical and clinical supply and commercial manufacturing.

View the full press release here

Contact of 3P Biopharmaceuticals:
Julie Lecourtois
Communications & Marketing at 3P Biopharmaceuticals
Phone: + 34 948 346 480

Our dedicated team of specialists will be happy to discuss any of your CDMO supply chain needs. Contact us on +34 948 346 480 or email withinus@3pbio.com

Related Content

3P Biopharmaceuticals celebrates its 15th anniversary with Juan Carlos Unzué.

Published: 29th July 2022
3P Biopharmaceuticals, a Navarre company founded in 2007, met with 370 employees in an exciting and joyful event looking back over its 15 years of trajectory.
Read more

3P Biopharmaceuticals and Biosergen complete together the manufacture of biomass for the Mucormycosis “Black Fungus” clinical phase II trial.

Published: 11th July 2022
3P Biopharmaceuticals has completed the manufacture of BSG005 biomass planned for its client Biosergen. The client also recently announced Phase II clinical trial of BSG005 against Mucormycosis, otherwise known as the Black Fungus.
Read more

Regional Minister Irujo presents the Navarra Health Cluster

Published: 28th June 2022
This morning, the Regional Minister for Economic and Business Development, Mikel Irujo, presented the Navarra Health Cluster, seeking to position the region as a European benchmark in personalized medicine, one of the priorities of the S4 Smart Specialisation Strategy. The initiative, which stems from the sector's demand and is led by a driving group, is now open to other companies and entities interested in participating.
Read more

Get in touch

Let’s discuss your biologics journey.

Discover more about our people, our passion, and how we can work together to improve lives.